Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Standard Biotools Inc (LAB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | 0.05 | SEC | ||
| 2023 Q2 | 10,014 | 0.05 | Add 36.13% | 0.01 | $241.33 | $2,416,679 | SEC |
| 2023 Q1 | 7,356 | 0.04 | Buy | 0.04 | $229.42 | $1,687,614 | SEC |
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q1 | 367 | <0.01 | Reduce 55.84% | <0.01 | $256.13 | $94,000 | SEC |
| 2020 Q4 | 831 | <0.01 | Reduce 90.91% | 0.03 | $203.37 | $169,000 | SEC |
| 2020 Q3 | 9,143 | 0.03 | Buy | 0.03 | $188.23 | $1,721,000 | SEC |
| 2020 Q2 | 0 | 0.00 | Sell 100.00% | 0.04 | SEC | ||
| 2020 Q1 | 13,637 | 0.04 | Add 28.32% | <0.01 | $126.42 | $1,724,000 | SEC |
| 2019 Q4 | 10,627 | 0.03 | Add 36.14% | <0.01 | $169.19 | $1,798,000 | SEC |
| 2019 Q3 | 7,806 | 0.02 | Buy | 0.02 | $167.95 | $1,311,000 | SEC |
| 2019 Q1 | 0 | 0.00 | Sell 100.00% | 0.17 | SEC | ||
| 2018 Q4 | 88,200 | 0.17 | Buy | 0.17 | $126.36 | $11,145,000 | SEC |
| 2002 Q4 | 0 | 0.00 | Sell 100.00% | 0.95 | SEC | ||
| 2002 Q3 | 1,815,000 | 0.95 | Buy | 0.95 | $33.78 | $61,311,000 | SEC |